What are the recommended Anti-Tuberculosis Treatment (ATT) doses for drug-susceptible tuberculosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Anti-Tuberculosis Treatment (ATT) Doses for Drug-Susceptible Tuberculosis

For drug-susceptible tuberculosis, the recommended daily doses for adults are: isoniazid 5 mg/kg (typically 300 mg), rifampin 10 mg/kg (typically 600 mg), pyrazinamide 15-30 mg/kg (maximum 2g), and ethambutol 15-25 mg/kg. 1, 2

First-Line Drug Dosing for Adults

Daily Dosing (Preferred Regimen)

  • Isoniazid: 5 mg/kg (typically 300 mg) daily 1
  • Rifampin: 10 mg/kg (typically 600 mg) daily 1
  • Pyrazinamide: 15-30 mg/kg daily (maximum 2g) 2
  • Ethambutol: 15-25 mg/kg daily 1
  • Pyridoxine (vitamin B6): 25-50 mg daily should be given with isoniazid to all persons at risk of neuropathy (pregnant women, breastfeeding infants, persons with HIV, diabetes, alcoholism, malnutrition, chronic renal failure, or advanced age) 1

Intermittent Dosing Options

  • Twice-weekly dosing:

    • Isoniazid: 15 mg/kg (typically 900 mg) 1
    • Rifampin: 10 mg/kg (typically 600 mg) 1
    • Pyrazinamide: 50-70 mg/kg 2
    • Ethambutol: 50 mg/kg 1
  • Thrice-weekly dosing (only for non-HIV patients at low risk of relapse):

    • Isoniazid: 15 mg/kg (typically 900 mg) 1
    • Rifampin: 10 mg/kg (typically 600 mg) 1
    • Pyrazinamide: See daily dosing table 1
    • Ethambutol: See daily dosing table 1

First-Line Drug Dosing for Children

Daily Dosing (Preferred Regimen)

  • Isoniazid: 10-15 mg/kg daily 1
  • Rifampin: 10-20 mg/kg daily 1
  • Pyrazinamide: 35 (30-40) mg/kg daily 1
  • Ethambutol: 20 (15-25) mg/kg daily 1

Intermittent Dosing Options

  • Twice-weekly dosing:
    • Isoniazid: 20-30 mg/kg 1
    • Rifampin: 10-20 mg/kg 1
    • Pyrazinamide: 50 mg/kg 1
    • Ethambutol: 50 mg/kg 1

Second-Line Drug Dosing

Fluoroquinolones

  • Levofloxacin: 500-1000 mg daily for adults 1
  • Moxifloxacin: 400 mg daily for adults 1

Injectable Agents

  • Streptomycin: 15 mg/kg daily (maximum 1g) for adults 1
  • Amikacin/Kanamycin: 15 mg/kg daily for adults 1
  • Capreomycin: 15 mg/kg daily for adults 1

Other Second-Line Drugs

  • Cycloserine: 10-15 mg/kg total (usually 250-500 mg once or twice daily) for adults 1
  • Ethionamide: 15-20 mg/kg total (usually 250-500 mg once or twice daily) for adults 1
  • Para-aminosalicylic acid: 8-12 g total (usually 4000 mg 2-3 times daily) for adults 1

Important Clinical Considerations

  • For obese patients (>20% above ideal body weight), dosing based on ideal body weight may be preferred for initial doses 1
  • Therapeutic drug monitoring should be considered for obese patients 1
  • Rifabutin dose may need adjustment when used with protease inhibitors or non-nucleoside reverse transcriptase inhibitors 1
  • For patients with peripheral neuropathy, increase pyridoxine dose to 100 mg/day 1
  • Patients with decreased renal function may require the 15 mg/kg dose of injectable agents to be given only 3 times weekly to allow for drug clearance 1
  • Children with HIV infection and/or low body weight (4-7 kg) may require higher rifampin doses due to lower drug exposure and higher risk of unfavorable outcomes 3
  • Ethambutol should be used with caution in children whose visual acuity cannot be monitored 1

Standard Treatment Regimen

  • The established standard regimen consists of an initial phase (first 2 months) with daily rifampin, isoniazid, pyrazinamide, and ethambutol, followed by a continuation phase (next 4 months) with daily rifampin and isoniazid 4
  • Ethambutol can be omitted in the initial phase for patients with a low risk of isoniazid resistance (less than 4% primary resistance in the community) 4, 5
  • For TB meningitis and CNS tuberculosis, treatment should be extended to 12 months total 4, 5

By following these dosing recommendations and considering patient-specific factors, optimal treatment outcomes can be achieved while minimizing adverse effects in patients with drug-susceptible tuberculosis.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.